CA3063842A1 - Novel peptide and pharmaceutical composition for treating an eye disease comprising the same as an active pharmaceutical ingredient - Google Patents
Novel peptide and pharmaceutical composition for treating an eye disease comprising the same as an active pharmaceutical ingredient Download PDFInfo
- Publication number
- CA3063842A1 CA3063842A1 CA3063842A CA3063842A CA3063842A1 CA 3063842 A1 CA3063842 A1 CA 3063842A1 CA 3063842 A CA3063842 A CA 3063842A CA 3063842 A CA3063842 A CA 3063842A CA 3063842 A1 CA3063842 A1 CA 3063842A1
- Authority
- CA
- Canada
- Prior art keywords
- gly
- leu
- ala
- pro
- yde
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/02—Linear peptides containing at least one abnormal peptide link
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Ophthalmology & Optometry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR10-2017-0061250 | 2017-05-17 | ||
| KR20170061250 | 2017-05-17 | ||
| PCT/KR2018/005673 WO2018225961A1 (ko) | 2017-05-17 | 2018-05-17 | 신규한 펩타이드 및 이를 유효성분으로 포함하는 안구질환 치료용 약학 조성물 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3063842A1 true CA3063842A1 (en) | 2019-12-09 |
Family
ID=64566301
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3063842A Pending CA3063842A1 (en) | 2017-05-17 | 2018-05-17 | Novel peptide and pharmaceutical composition for treating an eye disease comprising the same as an active pharmaceutical ingredient |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US12037415B2 (enExample) |
| EP (1) | EP3643723B1 (enExample) |
| JP (2) | JP7680824B2 (enExample) |
| KR (2) | KR102287226B1 (enExample) |
| CN (1) | CN110945012A (enExample) |
| AU (1) | AU2018281617B2 (enExample) |
| BR (1) | BR112019024040A2 (enExample) |
| CA (1) | CA3063842A1 (enExample) |
| ES (1) | ES2982308T3 (enExample) |
| MX (1) | MX2019013799A (enExample) |
| RU (1) | RU2766160C2 (enExample) |
| SG (1) | SG11201912110YA (enExample) |
| WO (1) | WO2018225961A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12037415B2 (en) * | 2017-05-17 | 2024-07-16 | Yuyu Pharma, Inc. | Peptide and pharmaceutical composition for treating an eye disease comprising the same as an active pharmaceutical ingredient |
| TWI865470B (zh) * | 2018-11-14 | 2024-12-11 | 南韓商柳柳製藥股份有限公司 | 治療眼睛疾病之肽及醫藥組合物 |
| US11613558B2 (en) | 2018-11-14 | 2023-03-28 | Yuyu Pharma, Inc. | Peptides and pharmaceutical compositions for treating eye diseases |
| BR112021023477A2 (pt) * | 2019-05-21 | 2022-02-15 | Eyebio Korea | Novo composto peptídico, composição farmacêutica para prevenir ou tratar inflamação, composição de alimento para prevenir ou amenizar a inflamação e composição de cosmético tendo um efeito anti inflamatório |
| KR20210104460A (ko) * | 2020-02-17 | 2021-08-25 | 주식회사 아이바이오코리아 | 고체상 합성법을 이용한 펩타이드의 제조 방법 |
| WO2021191689A2 (en) * | 2020-03-05 | 2021-09-30 | Yuyu Pharma, Inc. | Treatment of inflammatory diseases with peptides and pharmaceutical compositions |
| MX2024006997A (es) * | 2021-12-13 | 2024-06-19 | Eyebiokorea Inc | Composicion para el tratamiento de la degeneracion macular que comprende un nuevo peptido. |
| KR102593936B1 (ko) * | 2021-12-13 | 2023-10-27 | 주식회사 아이바이오코리아 | 신규한 펩타이드를 포함하는 황반변성의 치료용 조성물 |
| KR102587729B1 (ko) * | 2023-02-27 | 2023-10-12 | 주식회사 아이바이오코리아 | 펩타이드를 포함하는 당뇨망막병증의 치료용 조성물 |
| KR102673860B1 (ko) * | 2023-08-10 | 2024-06-12 | (주)케어젠 | 안구 건조증의 개선 활성을 갖는 펩타이드 및 이의 용도 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6037135A (en) * | 1992-08-07 | 2000-03-14 | Epimmune Inc. | Methods for making HLA binding peptides and their uses |
| WO2007117444A2 (en) * | 2006-03-31 | 2007-10-18 | Yinghe Hu | Protein detection by aptamers |
| WO2009039854A2 (en) | 2007-09-27 | 2009-04-02 | Dako Denmark A/S | Mhc multimers in tuberculosis diagnostics, vaccine and therapeutics |
| US20090131303A1 (en) * | 2007-11-16 | 2009-05-21 | Bor-Shyue Hong | Methods and compositions for treating dry eye |
| JP4490498B2 (ja) * | 2008-09-30 | 2010-06-23 | 新田ゼラチン株式会社 | 疾病抑制剤 |
| UA113627C2 (xx) | 2011-05-27 | 2017-02-27 | Кристалічна форма циклоспорину a, фармацевтична композиція та спосіб лікування | |
| WO2013079213A1 (en) | 2011-11-30 | 2013-06-06 | Xigen Inflammation Ltd. | Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of dry eye syndrome |
| KR101438744B1 (ko) | 2012-08-02 | 2014-09-15 | 전남대학교산학협력단 | 아디포넥틴을 유효성분으로 포함하는 안구건조증 또는 염증성 안구표면 질환의 예방 또는 치료용 조성물 |
| KR101948156B1 (ko) | 2013-12-10 | 2019-02-14 | 인제대학교 산학협력단 | 알칼리 화상을 이용한 각막 혼탁증 동물모델 및 각막 혼탁증 예방 또는 치료용 약학조성물 |
| KR101555296B1 (ko) | 2013-12-10 | 2015-09-23 | 인제대학교 산학협력단 | 연골세포 유래 세포외 기질을 유효성분으로 함유하는 건성안 예방 또는 치료용 약학조성물 |
| KR101721059B1 (ko) | 2014-12-26 | 2017-03-30 | 주식회사 아이바이오코리아 | 안구 표면 질환 예방 또는 치료용 약학조성물 |
| KR101690539B1 (ko) | 2015-07-30 | 2016-12-29 | 주식회사 아이바이오코리아 | 건성안 예방 또는 치료용 약학조성물 |
| AU2016373364B2 (en) | 2015-12-14 | 2019-07-11 | Tsung-Chuan Ho | Short synthetic peptide and uses thereof |
| KR101798183B1 (ko) * | 2016-04-08 | 2017-11-15 | 주식회사 아이바이오코리아 | 건성안 예방 또는 치료용 약학조성물 |
| ES2822289T3 (es) | 2016-04-08 | 2021-04-30 | Eyebio Korea | Péptido a base de colágeno tipo II alfa-1 para su uso en el tratamiento de la degeneración macular |
| KR101795653B1 (ko) * | 2016-05-19 | 2017-11-09 | 인제대학교 산학협력단 | 콜라겐 타입 ii 펩타이드-아플리버셉트의 키메라 단백질을 유효성분으로 함유하는 혈관신생 억제용 조성물 |
| KR20180074928A (ko) | 2016-12-26 | 2018-07-04 | 주식회사 아이바이오코리아 | 건성안 예방 또는 치료용 동물 의약품 조성물 |
| US12037415B2 (en) | 2017-05-17 | 2024-07-16 | Yuyu Pharma, Inc. | Peptide and pharmaceutical composition for treating an eye disease comprising the same as an active pharmaceutical ingredient |
| TWI865470B (zh) * | 2018-11-14 | 2024-12-11 | 南韓商柳柳製藥股份有限公司 | 治療眼睛疾病之肽及醫藥組合物 |
| US11613558B2 (en) | 2018-11-14 | 2023-03-28 | Yuyu Pharma, Inc. | Peptides and pharmaceutical compositions for treating eye diseases |
| WO2021191689A2 (en) * | 2020-03-05 | 2021-09-30 | Yuyu Pharma, Inc. | Treatment of inflammatory diseases with peptides and pharmaceutical compositions |
-
2018
- 2018-05-17 US US16/614,123 patent/US12037415B2/en active Active
- 2018-05-17 EP EP18812841.7A patent/EP3643723B1/en active Active
- 2018-05-17 SG SG11201912110YA patent/SG11201912110YA/en unknown
- 2018-05-17 WO PCT/KR2018/005673 patent/WO2018225961A1/ko not_active Ceased
- 2018-05-17 BR BR112019024040-3A patent/BR112019024040A2/pt unknown
- 2018-05-17 ES ES18812841T patent/ES2982308T3/es active Active
- 2018-05-17 CA CA3063842A patent/CA3063842A1/en active Pending
- 2018-05-17 JP JP2019563617A patent/JP7680824B2/ja active Active
- 2018-05-17 RU RU2019141646A patent/RU2766160C2/ru active
- 2018-05-17 AU AU2018281617A patent/AU2018281617B2/en active Active
- 2018-05-17 KR KR1020180056745A patent/KR102287226B1/ko active Active
- 2018-05-17 CN CN201880047540.1A patent/CN110945012A/zh active Pending
- 2018-05-17 MX MX2019013799A patent/MX2019013799A/es unknown
-
2021
- 2021-07-30 KR KR1020210100394A patent/KR102498428B1/ko active Active
-
2023
- 2023-04-05 JP JP2023061251A patent/JP7775250B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP7680824B2 (ja) | 2025-05-21 |
| JP2023098936A (ja) | 2023-07-11 |
| BR112019024040A2 (pt) | 2020-09-24 |
| MX2019013799A (es) | 2020-08-13 |
| AU2018281617B2 (en) | 2022-06-30 |
| KR102498428B1 (ko) | 2023-02-20 |
| KR20210097670A (ko) | 2021-08-09 |
| EP3643723C0 (en) | 2024-05-15 |
| RU2019141646A (ru) | 2021-06-17 |
| JP7775250B2 (ja) | 2025-11-25 |
| EP3643723A1 (en) | 2020-04-29 |
| CN110945012A (zh) | 2020-03-31 |
| WO2018225961A1 (ko) | 2018-12-13 |
| US12037415B2 (en) | 2024-07-16 |
| EP3643723B1 (en) | 2024-05-15 |
| AU2018281617A1 (en) | 2019-12-05 |
| KR102287226B1 (ko) | 2021-08-11 |
| EP3643723A4 (en) | 2021-03-31 |
| SG11201912110YA (en) | 2020-01-30 |
| US20210024577A1 (en) | 2021-01-28 |
| RU2766160C2 (ru) | 2022-02-08 |
| ES2982308T3 (es) | 2024-10-15 |
| RU2019141646A3 (enExample) | 2021-07-28 |
| KR20180126406A (ko) | 2018-11-27 |
| JP2020520372A (ja) | 2020-07-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7775250B2 (ja) | 新規ペプチド及びその新規ペプチドを活性成分として含む眼疾患の治療のための医薬組成物 | |
| JP7522732B2 (ja) | 眼疾患治療用のペプチド及び医薬組成物 | |
| CA2746264C (en) | New 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication | |
| CA2645072A1 (en) | Substituted aminothiazole derivatives with anti-hcv activity | |
| WO2021191689A2 (en) | Treatment of inflammatory diseases with peptides and pharmaceutical compositions | |
| TR201816372T4 (tr) | Enzim inhibisyonu için etoksiketon bileşikleri. | |
| KR102058853B1 (ko) | 지질화 펩타이드의 수용성 염과 이의 제조 방법 및 용도 | |
| JP7834361B2 (ja) | 置換４－（［１，２，４］トリアゾロ［１，５－ａ］ピリジン－６－イル）チオフェン－２－カルボキサミド誘導体及びその使用 | |
| HK40017864A (en) | Novel peptide and pharmaceutical composition for treatment of eye diseases comprising same novel peptide as active ingredient | |
| CA3119921C (en) | Peptides and pharmaceutical compositions for treating eye diseases | |
| RU2819399C2 (ru) | Пептиды и фармацевтические композиции для лечения глазных болезней | |
| CN105636956A (zh) | 作为细胞坏死阻碍剂的吲哚化合物 | |
| HK40061089A (en) | Peptides and pharmaceutical compositions for treating eye diseases | |
| HK40061089B (en) | Peptides and pharmaceutical compositions for treating eye diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20220927 |
|
| B12 | Application deemed to be withdrawn, abandoned or lapsed |
Free format text: ST27 STATUS EVENT CODE: N-2-6-B10-B12-B303 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: DEEMED ABANDONED - FAILURE TO RESPOND TO AN EXAMINER'S REQUISITION Effective date: 20240718 |